Autoimmune Diseases  >>  fingolimod  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fingolimod / Generic mfg.
NCT02193217: A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303

Completed
1
81
Europe
MT-1303-Low, MT-1303-High, Fingolimod, Placebo
Mitsubishi Tanabe Pharma Corporation
Relapsing-remitting Multiple Sclerosis
12/14
01/15

Download Options